| P50 | author | Catherine Duggan | Q43077784 |
| | Anne McTiernan | Q91493819 |
| P2093 | author name string | Ching-Yun Wang | |
| | Liren Xiao | |
| P2860 | cites work | Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative | Q28165551 |
| | Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 |
| | A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer | Q28195274 |
| | A randomized trial of aspirin to prevent colorectal adenomas | Q28195296 |
| | Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee | Q29619180 |
| | Analgesic use and sex steroid hormone concentrations in postmenopausal women | Q33780860 |
| | Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women | Q36099670 |
| | Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence | Q36267669 |
| | Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial | Q36910418 |
| | Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial | Q37019565 |
| | No effect of aspirin on mammographic density in a randomized controlled clinical trial | Q37210539 |
| | Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. | Q37478905 |
| | Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. | Q38532713 |
| | Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis | Q40038248 |
| | Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. | Q40462696 |
| | Aromatase and breast cancer susceptibility | Q41726428 |
| | Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations | Q44177107 |
| | Nonsteroidal antiinflammatory drugs and breast cancer | Q44378169 |
| | Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma | Q44464279 |
| | Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women | Q46694709 |
| | A critical evaluation of simple methods for the estimation of free testosterone in serum | Q49081910 |
| | Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. | Q52719647 |
| | Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas | Q73397053 |
| | Cyclooxygenase-2 inhibitors in tumorigenesis (part I) | Q77470864 |
| | Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens | Q77994194 |
| | Physical activity and risk of lung cancer | Q78239082 |
| | Relation of BMI and physical activity to sex hormones in postmenopausal women | Q79216212 |
| | Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats | Q84136047 |
| | Breast cancer risk reduction: no pain, no gain? | Q84884043 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| | estrogen | Q277954 |
| P304 | page(s) | 906-912 | |
| P577 | publication date | 2014-06-12 | |
| P1433 | published in | Cancer Prevention Research | Q2665103 |
| P1476 | title | Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial | |
| P478 | volume | 7 | |